Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 66 entries
View as:

Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02979366 Org: User:
Start: 03/15/17 End: 05/11/20 Due: 05/11/21

A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04067518 Org: User:
Start: 10/17/19 End: 02/04/22 Due: 02/04/23

A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT04956666 Org: User:
Start: 06/15/21 End: 01/23/23 Due: 01/23/24

Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT04629443 Org: User:
Start: 02/17/21 End: 08/25/23 Due: 08/25/24

Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02697058 Org: User:
Start: 03/30/16 End: 08/28/18 Due: 08/28/19

S90652 in Paediatric Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00202592 Org: User:
Start: 11/30/03 End: 04/30/10 Due: 04/30/11

Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients

Phase: N/A Priority: Normal
NCT ID: NCT00202540 Org: User:
Start: 06/30/05 End: 03/29/06 Due: 03/29/07

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT02746952 Org: User:
Start: 08/01/16 End: 07/28/20 Due: 07/28/21

A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT04954326 Org: User:
Start: 05/07/21 End: 05/20/22 Due: 05/20/23

Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01108393 Org: User:
Start: 05/31/10 End: 04/30/13 Due: 04/30/14

Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT06478212 Org: User:
Start: 01/22/25 End: 06/30/28 Due: 06/30/29

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06501625 Org: User:
Start: 12/16/24 End: 09/13/27 Due: 09/13/28

Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05820880 Org: User:
Start: 05/06/19 End: 02/23/22 Due: 02/23/23

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03343197 Org: User:
Start: 03/20/18 End: 03/28/25 Due: 03/28/26

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02073994 Org: User:
Start: 03/01/14 End: 01/04/24 Due: 01/04/25

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02805439 Org: User:
Start: 03/31/16 End: 04/30/17 Due: 04/30/18

Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

Phase: N/A Priority: Normal
NCT ID: NCT03435250 Org: User:
Start: 03/04/18 End: 04/20/23 Due: 04/20/24

A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05786924 Org: User:
Start: 04/18/23 End: 12/31/26 Due: 12/31/27

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03173248 Org: User:
Start: 06/26/17 End: 06/30/26 Due: 06/30/27

Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03964025 Org: User:
Start: 07/01/21 End: 01/01/22 Due: 01/01/23

Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04591808 Org: User:
Start: 09/09/21 End: 04/08/22 Due: 04/08/23

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02808442 Org: User:
Start: 06/03/16 End: 11/04/20 Due: 11/04/21

Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT06225999 Org: User:
Start: 04/25/24 End: 01/01/26 Due: 01/01/27

A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

Phase: N/A Priority: Normal
NCT ID: NCT03306394 Org: User:
Start: 10/18/16 End: 11/30/20 Due: 11/30/21

Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris

Phase: N/A Priority: Normal
NCT ID: NCT00202566 Org: User:
Start: 06/30/05 End: 10/31/07 Due: 10/31/08